Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$279K Sell
154
-5
-3% -$8.67K 0.01% 646
2026
Q2
$316K Sell
159
-17
-10% -$27.1K 0.01% 606
2026
Q1
$232K Buy
176
+55
+45% +$75.4K 0.01% 680
2025
Q4
$129K Buy
121
+4
+3% +$4.17K ﹤0.01% 807
2025
Q3
$113K Buy
117
+16
+16% +$12.6K ﹤0.01% 806
2025
Q2
$81K Sell
101
-2
-2% -$1.44K ﹤0.01% 790
2025
Q1
$68K Buy
+103
New +$74.9K ﹤0.01% 796
2022
Q3
– Sell
-59
Closed -$28K – 498
2022
Q2
$28K Buy
+59
New +$32.9K ﹤0.01% 778

Other funds holding ASML

CX Institutional's ASML Position: Q3 2026 in Review

CX Institutional reduced its ASML (ASML) stake by 3.1% in Q3 2026, selling an estimated $8.67K and leaving 154 shares worth $279K. The position accounts for 0.01% of the portfolio, ranked #646.

CX Institutional first reported a position in ASML in Q2 2022 and has held it in 8 quarters since. The position peaked at $316K in Q2 2026. 118 funds tracked by Wall St. Rank hold ASML as of Q3 2026.

  • CX Institutional held 154 shares of ASML worth $279K as of Q3 2026.
  • CX Institutional sold 5 ASML shares in Q3 2026, an estimated $8.67K.
  • ASML made up 0.01% of CX Institutional's portfolio in Q3 2026, its #646 holding.
  • CX Institutional first reported a position in ASML in Q2 2022 and has held it in 8 quarters since.
  • CX Institutional's ASML position peaked at $316K in Q2 2026.
  • 118 funds tracked by Wall St. Rank held ASML as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.